Linglin Yang
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Electrospun Nanofibers in Biomedical Applications
- Immunology top 5%
- Immune cells in cancer
- Immunotherapy and Immune Responses
Papers in
-
- Head and Neck Cancer Studies 9
-
- Nanoparticle-Based Drug Delivery 6
- Electrospun Nanofibers in Biomedical Applications 3
- Co-authors
- Suzanne Ostrand‐Rosenberg (1 shared paper)Pratima Sinha (1 shared paper)Jeff Leips (1 shared paper)Virginia K. Clements (1 shared paper)Stephanie K. Bunt (1 shared paper)Shaozhi Fu (22 shared papers)Jingbo Wu (20 shared papers)Biqiong Wang (6 shared papers)
- Journals
- International Journal of Nanomedicine (3 papers)Oncotarget (3 papers)Drug Delivery (3 papers)Cancer Management and Research (2 papers)PLoS ONE (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Linglin Yang
58 papers receiving 2k citations
Peers
Comparison fields: 5 of 99
- Biomaterials 270
- Immunology 380
- Oncology 351
- Molecular Medicine 103
- Biological Psychiatry 17
Countries citing papers authored by Linglin Yang
This map shows the geographic impact of Linglin Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linglin Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linglin Yang more than expected).
Fields of papers citing papers by Linglin Yang
This network shows the impact of papers produced by Linglin Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linglin Yang. The network helps show where Linglin Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Linglin Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 550 | |
| 2 | 2021 | 166 | |
| 3 | 2016 | 114 | |
| 4 | 2013 | 84 | |
| 5 | 2021 | 73 | |
| 6 | 2014 | 67 | |
| 7 | 2009 | 62 | |
| 8 | 2021 | 56 | |
| 9 | 2020 | 51 | |
| 10 | 2019 | 46 | |
| 11 | 2018 | 35 | |
| 12 | 2021 | 35 | |
| 13 | 2017 | 34 | |
| 14 | 2017 | 34 | |
| 15 | 2018 | 33 | |
| 16 | 2017 | 31 | |
| 17 | 2017 | 30 | |
| 18 | 2018 | 29 | |
| 19 | 2018 | 28 | |
| 20 | 2009 | 26 |
About Linglin Yang
Linglin Yang is a scholar working on Otorhinolaryngology, Biomaterials, Oncology, Psychiatry and Mental health and Radiology, Nuclear Medicine and Imaging, having authored 60 papers that have together received 2k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (9 papers), Angiogenesis and VEGF in Cancer (7 papers), Epilepsy research and treatment (6 papers), Nanoparticle-Based Drug Delivery (6 papers), Chemokine receptors and signaling (4 papers), Advanced Neuroimaging Techniques and Applications (3 papers), Electrospun Nanofibers in Biomedical Applications (3 papers) and Hydrogels: synthesis, properties, applications (3 papers). The work is most often cited by research in Biomaterials (270 citations), Immunology (380 citations), Oncology (351 citations), Molecular Medicine (103 citations) and Biological Psychiatry (17 citations). Linglin Yang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Suzanne Ostrand‐Rosenberg, Pratima Sinha, Jeff Leips, Virginia K. Clements, Stephanie K. Bunt, Shaozhi Fu, Jingbo Wu, Biqiong Wang, Juan Fan and Xinfeng Yu. Their work appears in journals such as International Journal of Nanomedicine, Oncotarget, Drug Delivery, Cancer Management and Research and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.